Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USP
- Published
- 17 Dec 2025
- Units affected
- 52,128 bottles
- Agency
- FDA
- Country
- United States
The hazard
Defective container - seal not adhering to bottles
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
- Brand / company
- Lupin Pharmaceuticals Inc.
- Codes / lots
- Lot # QB00865, exp. date Feb 2028
- Distribution
- Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 17 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.